Cesano Alessandra's Form 4 filing
Puma Biotechnology, Inc. (PBYI) · filed Sep 16, 2026
- Accession no.
- 0001437749-26-030593
- Filed
- Sep 16, 2026, 9:06 PM ET
- Trade date
- Sep 14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $567.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cesano AlessandraCIK 0001827015 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | $2.93 | +$146,500 | 118,850 | Direct | |
| Sep 14, 2026 | Common Stock | SSaleDisposed | −62,150 | $9.12 | −$566,994.45 | 56,700 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.